CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. AGIOa leader in breakthrough therapies for cellular metabolism in rare diseases, today announced that
– Actively initiating the Phase 3 ENERGIZE and ENERGIZE-T studies evaluating PYRUKYND® in adults with non-transfusion-dependent or transfusion-dependent α- or β-thalassemia – – Agios to
CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. AGIO, a leader in breakthrough cellular therapies for rare and genetically defined diseases, today
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents
Under Florida’s no-fault system, your PIP pays medical bills (typically 80%) and lost wages (about 60%) after a crash, regardless of fault, but prompt action is crucial. Get treatment within
injuredly News Provide the latest news. All News World News, Business News, Health Care, Life Style. All News Around the World Update On This Website.